Cargando…
Task Force I: Direct Cardiovascular Implications of Emerging Infectious Diseases and Biological Terrorism Threats
Autores principales: | Baddour, Larry M., Zheng, Zhi-Jie, Labarthe, Darwin R., O’Connor, Siobhán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132746/ https://www.ncbi.nlm.nih.gov/pubmed/17394979 http://dx.doi.org/10.1016/j.jacc.2007.01.019 |
Ejemplares similares
-
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(®) trial
por: Fitchett, David, et al.
Publicado: (2016) -
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015
por: Antman, Elliott M., et al.
Publicado: (2015) -
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016) -
Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
por: Anesi, Judith
Publicado: (2022) -
Knowledge and practices regarding safe household cleaning and disinfection for COVID-19 prevention — United States, May 2020
por: Gharpure, Radhika, et al.
Publicado: (2020)